▲ Peaking
Business
HP names former GSK chief Emma Walmsley as CEO
HP Inc. has appointed former GSK chief Emma Walmsley as its new CEO to lead the company's strategic push into AI-powered PCs.
Gsk
9 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Exclusive | GSK Sees Cancer-Drug Pipeline Nearly Doubling Next Year After Dealmaking Spree
GSK anticipates its oncology clinical pipeline will nearly double in 2027 following an aggressive period of dealmaking and strategic acquisitions.
◼ Archived
Business
Exclusive: AI startup Chai lands GSK deal, its sixth pharma partner in nine months
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
What to know about the new mRNA flu vaccine
Health coverage highlights FDA approval of Moderna's new mRNA flu vaccine and emerging studies on broader antibody responses.
◼ Archived
Business
🔮 fades ✓
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✗
GSK catches phase 3 fever after mRNA flu vaccine beats standard shots
GSK advances its mRNA flu vaccine candidate to phase 3 trials following successful mid-stage performance data.
◼ Archived
Business
🔮 fades ✓
There’s a big change for this year’s flu shot: When should you be vaccinated?
GSK is advancing a new mRNA flu vaccine to Phase III trials after the candidate outperformed standard vaccinations in earlier testing.
◼ Archived
Health
🔮 fades ✗
Shingles vaccine linked to 24% lower dementia risk
Recent studies link the shingles vaccine to significant reductions in dementia and cardiovascular disease risks.
◼ Archived
Business
🔮 fades ✗
GSK unveils 3-year cost-saving plan to fund late-stage R&D, move research HQ to AZ's backyard
GSK is launching a $2.5 billion cost-saving initiative to accelerate its late-stage drug pipeline and relocate its research headquarters.